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Fungal properties and epidemiology
Rare systemic fungal infections in Europe are blastomycosis (caused by
Blastomyces dermatitidis), histoplasmosis (caused by Histoplasma capsu-
latum) and coccidioidomycosis (caused by Coccidioides immitis). In
endemic areas, these infections are more frequent in dogs; scientific
data for cats are scarce and mainly based on a few retrospective case
series or reports.
These diseases are endemic in some areas of the Americas, but in
recent years more cases have been reported from non-endemic areas.1–5
At risk are mainly outdoor, free-roaming cats with access to fungal
organisms in the soil.1 However, an outbreak of blastomycosis has been
reported in an urban non-endemic area (Chicago, Illinois), in five
indoor cats; unusual drought was suggested as the most likely cause.2
Histoplasmosis has also been diagnosed in indoor cats, associated
with exposure to contaminated soil linked to construction work, potted
plants and unfinished basements.6,7 The first reported cases of histo-
plasmosis in Europe and Japan have been published in recent years. 
In both cases diagnosis was confirmed by post-mortem examination,
involving histology, special stains and immunohistochemistry.3,5
Italy, Germany and Turkey should be considered endemic areas for
histoplasmosis, as suggested by the European Confederation of
Medical Mycology
Working Group.8
Few case reports and
one case series of coc-
cidioidomycosis have
been published so far,
and only in endemic
areas. One case in a
cat imported from
the USA has been
diagnosed in
Portugal.4
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Overview: Rare fungal infections, including 
those hitherto not reported in Europe, may occur
sporadically in non-endemic areas, or imported
cases may be seen. 
Infections: Blastomycosis is mainly seen in 
North America; no cases have been reported 
in Europe. Histoplasmosis, which is endemic 
in the eastern US, Central and South America, 
has been diagnosed in Japan and Europe.
Coccidioidomycosis is endemic in the
southwestern US, Central and South America; only
one imported case has been reported in Europe.
The primary mode of transmission is inhalation of
conidia or spores from the environment.
Disease signs: Most feline cases present with a
combination of clinical signs (mainly respiratory,
along with skin, eye, central nervous system and
bone). Lymphadenopathy and systemic signs
may be present.
Diagnosis: Diagnosis is based on fungal
detection by cytology and/or histology.
Commercial laboratories do not routinely
perform fungal culture. Diagnosis of
coccidioidomycosis, which is more difficult, 
may be supported by antibody detection.
Treatment: Treatment consists of prolonged
systemic antifungal therapy, with itraconazole 
as the first-choice agent for histoplasmosis and
blastomycosis. The prognosis is good if owner
compliance is adequate and adverse drug
effects do not occur. 
Prevention: Cat owners travelling to endemic
areas should be warned about these diseases.
There is no zoonotic risk. 
*The ABCD is grateful to Professor Lluís Ferrer, of the Foster
Hospital for Small Animals, Cummings School of Veterinary
Medicine, Tufts University, USA, who, though not a member
of the Board, contributed to this article.
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Pathogenesis
Fungal systemic mycoses are not contagious
among cats, with infection occurring after the
organism is contracted from the environment.
Inhalation of aerosolised conidia or spores
establishes a primary infection site in the lungs;
thereafter, yeast dissemination to the lymphat-
ic, skeletal and central nervous (CNS) systems
occurs, as well as to the eyes and skin, with
pyogranulomatous inflammation.9
Clinical presentation 
Systemic mycoses generally produce a 
combination of clinical signs related to the 
target sites of infection, including the 
respiratory tract (which is usually the primary
focus), bone, CNS, eyes, lymph nodes and
skin.1,9
< Blastomycosis Cats usually show
pneumonia (dyspnoea, tachypnoea,
coughing) and skin disease (non-ulcerated
dermal masses or large abscesses) and non-
specific signs like fever, lethargy, anorexia
and weight loss.10,11 Chorioretinitis and
common CNS signs may also be present in
cats with disseminated disease.11 CNS
infection rarely occurs without evidence of
systemic disease.12 Lymph node involvement
is not a common feature.10,13 Abnormal blood
values are non-specific, indicative of an
inflammatory process. In one cat with
pulmonic and cutaneous blastomycosis,
hypercalcaemia and increased levels of
calcitriol were found, which returned to
normal after treatment.14 Thoracic
radiographs mainly demonstrate nodular
interstitial to alveolar patterns and areas of
consolidation. Diffuse bronchial patterns are
also observed.10,14 Immunosuppression and
retroviral infection have not usually been
present in the cases reported.9,10
< Histoplasmosis Cats usually show
pneumonia, gastrointestinal disease and
sometimes progressive disseminated
disease.15,16 Cases have also been reported of
disseminated infections without respiratory
signs.16,17 Intestinal involvement may occur,
with pyogranulomatous lesions in the small
bowel and mesenteric lymph node
enlargement.5 In disseminated disease, the
liver, lymph nodes, eyes and bone marrow
are affected. One case of disseminated
histoplasmosis presenting as an acquired skin
fragility syndrome has been reported.18
< Coccidioidomycosis Cats usually show
skin, respiratory, musculoskeletal,
neurological and ocular signs.19,20 Ocular
disease (anterior uveitis, granulomatous
chorioretinitis, blindness) has been diagnosed
in cats without systemic signs.21
REV IEW / ABCD guidelines on rare systemic mycoses
Diagnosis
Diagnosis is usually based on the demonstra-
tion of yeast cells in affected tissues by cytol-
ogy and/or histology.1,9,15
Cytology
The characteristic morphology of the yeast
cells (B dermatitidis – thick-walled, 8–12 μm
cells without a capsule; H capsulatum – round
to oval intracellular yeast cells with a
basophilic centre surrounded by a light halo)
is in most cases sufficient to confirm the diag-
nosis. Respiratory tract (by lung fine needle
aspiration or bronchoalveolar lavage), skin,
lymph node (not in blastomycosis) and bone
marrow (histoplasmosis) samples are most
suitable for diagnosis.9,15
Cytology is less reliable for the diagnosis of
coccidioidomycosis.19,21,22
Histopathology
Histology is needed for diagnosis when cytol-
ogy fails, especially in coccidioidomycosis.22
Pyogranulomatous inflammatory responses
and the presence of yeasts with the typical
morphology in each case are diagnostic.
Special staining for fungal organisms 
(periodic acid-Schiff, Gridley’s or Gomori
methenamine silver) may improve the 
sensitivity.9,15,22
Culture
Culture is the gold standard for diagnosis, 
but is not frequently performed in practice.
Concerns about the potential risks to laborato-
ry personnel handling the samples should
govern the procedures.
Other tests
Tests have been developed for the detection of
blastomycosis antigen in blood and urine of
dogs and humans.23 The highest sensitivity is
achieved by testing both blood and urine.
Cross-reactions occur with histoplasmosis, as
the antigen is identical for both organisms; the
test may therefore be seen as an assay to
screen for both mycoses.24 Antigen detection
tests have also been used to monitor response
(including duration of response) to treat-
ment.23,25 Antigen testing has not been criti -
cally evaluated in cats, and recommendations
about its use cannot be given.
Assays to detect antibodies against these
fungal organisms have been developed, but
they are of low sensitivity and specificity 
for blastomycosis and histoplasmosis, not 
discriminating between current disease and
previous exposure.1,9
In contrast, serology using an agar gel
immunodiffusion test is the basis for the 
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sensitivity (83%) has been established in cats
by a retrospective study [EBM grade III].19
False-negative results may be expected in 
the first 2 months of acute infection.
Coccidioidomycosis is usually diagnosed by a
combination of serology, cytology and/or
histopathology.19,21,22
Treatment 
No prospective studies exist on the treatment
of feline systemic mycoses. Available data on
treatment are based on retrospective studies
and case reports.
Itraconazole is currently the treatment of
choice for blastomycosis and histoplasmosis
[EBM grade III].1,16,26 Amphotericin B and flu-
conazole may be used as well, especially in
severe cases or those with CNS signs [EBM
grade III].1,16 In a study of eight cats with
histoplasmosis, long-term itraconazole treat-
ment was well tolerated and cured all the
patients [EBM grade III].15 
Ketoconazole or fluconazole have been used
most frequently in feline coccidioidomycosis
[EBM grade III].1,19 In a recent report of cats
with ocular coccidioidomycosis, fluconazole
was effective, although long term treatment
was necessary in one case [EBM grade IV].21
Table 1 lists the treatment options for these
infections.
There are no vaccines available.
Disease in humans
Systemic mycoses are not considered zoonotic,
as they are not contagious among cats nor 
generally transmitted by cat-to-human contacts.
Infection occurs by contact with spores or coni-
dia from the environment where they reside as
soil saprophytes. Concerns are justified about
the potential danger for laboratory personnel
manipulating samples for culture. 
Exceptionally, the first case of cat-to-human transmis-
sion of coccidioidomycosis has recently been reported; the infection was




Disease Drug Dose and frequency Comments
Blastomycosis Itraconazole 10 mg/kg PO q24h Long-term treatment, commonly >3 months
Amphotericin B 0.25 mg/kg q48h IV to a
total dose of 4–16 mg/kg
Often combined with azoles in severely
affected animals, including those with
hypoxaemia or CNS signs. Risk of significant
nephrotoxicity; monitor BUN and creatinine
Fluconazole 2.5–10 mg/kg PO q12h Preferred if CNS involvement. Good
absorption without food. Monitor liver
enzymes
Histoplasmosis Itraconazole 10 mg/kg PO q24h Duration 2–4 months. 100% efficacy in one
small case series
Amphotericin B 0.25 mg/kg q48h IV to a
total dose of 4–16 mg/kg
Combine with itraconazole in severe cases
Coccidioidomycosis Ketoconazole 10 mg/kg PO q12h Administer with food for good absorption.
Hepatotoxicity possible; monitor liver
enzymes. Duration 3–6 months required
Fluconazole 10 mg/kg PO q12h
BUN = blood urea nitrogen, CNS = central nervous system
Treatment of rare systemic mycosesTable 1
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< Cat owners travelling to endemic areas should be warned about
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< Italy, Germany and Turkey should be considered endemic areas
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< Fine-needle aspirates and cytology are of high sensitivity in the
diagnosis of blastomycosis and histoplasmosis. 
< Itraconazole, administered over several months, is the first-line
treatment for blastomycosis and histoplasmosis, and
fluconazole for coccidioidomycosis.
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